Abivax (ABVX) Assets Average (2022 - 2026)

Abivax's Assets Average history runs 4 years deep, the most recent figure standing at $660.4 million for Q1 2026.

• On a quarterly basis, Assets Average rose 234.47% year-over-year to $660.4 million in Q1 2026; TTM through Mar 2026 was $660.4 million, a 234.47% increase from a year earlier, with the FY2025 full-year figure at $451.1 million, up 57.2% from the prior year.
• Assets Average declined to $660.4 million in Q1 2026 per ABVX's latest filing, from $721.2 million in the prior quarter.
• Across five years, Assets Average topped out at $721.2 million in Q4 2025 and bottomed at $101.0 million in Q4 2022.
• The 4-year median for Assets Average is $214.5 million (2023), against an average of $357.0 million.
• Across the five-year window, Assets Average jumped 112.33% in 2023 and soared 234.47% in 2026, its largest moves.
• Year by year, Assets Average stood at $101.0 million in 2022, then soared by 112.33% to $214.5 million in 2023, then surged by 236.26% to $721.2 million in 2025, then dropped by 8.44% to $660.4 million in 2026.
• Per Business Quant, the three latest ABVX Assets Average figures stand at $660.4 million (Q1 2026), $721.2 million (Q4 2025), and $448.9 million (Q3 2025).